Credit Information
Credit Type
* AMA PRA Category 1™
Number of Credits
1
Course Overview
This course provides an in-depth exploration of the complex considerations involved in managing stroke prevention in patients with atrial fibrillation (AFIB) through anticoagulation and antiplatelet therapy. It delves into the risks and benefits of dual and triple therapy regimens, addressing the challenges of balancing stroke prevention against the potential for bleeding complications. The course includes discussions on patient stratification, risk assessment tools, and the latest evidence-based guidelines. Practical approaches for navigating therapy choices in diverse patient populations, including those with coexisting cardiovascular conditions or prior thrombotic events, are also presented. Through case studies and expert insights, participants will gain a nuanced understanding of tailoring treatment plans to optimize patient outcomes.
Course Objectives
After completing this activity, the participant will:
Enhance clinical practice by promoting personalized treatment approaches for AFib patients.
Improving clinicians' understanding of drug interactions and management strategies.
Fostering better adherence to the latest evidence-based guidelines for anticoagulation therapy.
Target Audience
Physicians, sonographers, and others who perform and/or interpret ultrasound. Physicians, physician assistants, nurse practitioners, and other healthcare professionals who are involved in the care of patients on anticoagulant and antiplatelet therapy
* AMA PRA Category 1 ™ credits are used by physicians and other groups like PAs and certain nurses. Category 1 credits are accepted by the ARDMS, CCI, ACCME, and Sonography Canada.
